All cancer types, Oesophageal cancer, Stomach cancer
Results
Phase 1/2
This trial looked at fexagratinib and chemotherapy for people with cancer that had come back after treatment.
The trial was supported by Cancer Research UK. It was open for people to join between 2012 and 2015. The research team analysed the results in 2019. There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 1 March 2012
Recruitment end: 31 January 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NHS Greater Glasgow and Clyde
NIHR Clinical Research Network: Cancer
University of Glasgow
This is Cancer Research UK trial number CRUKD/11/003.
Last reviewed: 21 Apr 2024
CRUK internal database number: 7819
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
